A naukri.com initiative
Bio News
Bioengineer
4d
252
Image Credit: Bioengineer
Mitochondrial Protein Drives Heart Injury via RIG-I
- A study published in Nature Communications reveals the role of mitochondrial antiviral signaling proteins in exacerbating heart injury through RIG-I signaling pathways during ischemia-reperfusion injury.
- Ischemia-reperfusion injury occurs when blood supply to the heart is interrupted and then restored, contributing to further damage through complex cellular and molecular processes.
- Researchers discovered that the protein MAVS, known for its role in viral immune responses, unexpectedly promotes tissue damage in cardiac IRI by interacting with the RIG-I signaling axis.
- Activation of the MAVS-RIG-I pathway leads to increased production of pro-inflammatory cytokines, exacerbating cardiac inflammation and promoting cell death in cardiomyocytes.
- Genetic knockout of MAVS or RIG-I resulted in reduced infarct sizes and improved cardiac function after ischemia-reperfusion, suggesting therapeutic potential in targeting this pathway.
- Mitochondrial damage triggers a maladaptive signaling loop involving MAVS and RIG-I, indicating a dual role of mitochondrial innate immunity in protecting against pathogens and intensifying tissue damage.
- Understanding the MAVS-RIG-I pathway provides a promising target for future drug development to reduce post-ischemic cardiac damage, with implications for other forms of sterile inflammation and tissue injury.
- The study underscores the critical role of mitochondria in regulating immune and inflammatory responses in the heart, offering new insights into immunomodulatory therapies for cardiovascular diseases.
- Exploring selective inhibitors for MAVS or RIG-I signaling could lead to therapeutic strategies that mitigate reperfusion injury without compromising antiviral immunity, improving patient outcomes.
- Additionally, monitoring mitochondrial nucleic acids released during ischemia may serve as biomarkers for assessing myocardial injury severity and treatment responses, enhancing clinical risk stratification.
- These findings highlight the importance of understanding the interplay between innate immunity and mitochondrial function under stress conditions, paving the way for innovative therapies to protect the heart.
Read Full Article
15 Likes
Bioengineer
4d
122
Image Credit: Bioengineer
Finnish Researchers Uncover Potential Reasons Behind Breast Cancer’s Variable Response to Immunotherapy
- Researchers at the University of Helsinki have uncovered reasons behind breast cancer's variable response to immunotherapy by focusing on the mechanical properties of the tumor microenvironment.
- The study reveals that the softness or stiffness of the extracellular matrix surrounding tumor cells plays a crucial role in immune cell infiltration and activity, affecting tumor growth.
- Using fresh breast cancer tissue samples, the researchers found that a softer tumor microenvironment leads to immunosuppression through COX-FGF2 signaling, hindering effective anti-tumor responses.
- The discovery of the COX-FGF2 signaling pathway's role in immune modulation presents potential therapeutic targets to enhance immunotherapy outcomes for breast cancer patients.
- Variability in tissue stiffness could serve as a biomarker for predicting immunotherapy response, aiding in the selection of personalized treatment strategies for better patient outcomes.
- The research's unique access to high-quality human tissue specimens and collaboration between academia and healthcare institutions have attracted international interest for its translational medicine model.
- Patient-driven research contributions have been pivotal in advancing the study of live, patient-derived tumors, leading to potential advancements in cancer therapies.
- The study highlights the importance of considering tissue physicality in cancer biology and suggests novel therapeutic approaches targeting the mechanical microenvironment to improve treatment efficacy.
- Integrating biomechanical perspectives into oncology could provide a more comprehensive understanding of tumor vulnerabilities and potentially convert resistant tumors into ones susceptible to immune system attack.
- The findings emphasize the future of personalized cancer care by leveraging insights into tissue properties and immune evasion mechanisms to develop targeted interventions for improved patient outcomes.
- This innovative research heralds a new frontier in cancer treatment, advocating for the integration of physical tissue assessments with genetic profiling to enhance precision oncology and expand benefits to a wider patient population.
Read Full Article
7 Likes
Bioengineer
4d
114
Image Credit: Bioengineer
Breakthrough in Immune System Research Uncovers Promising Approach to Alzheimer’s Treatment
- A groundbreaking study from the University of Virginia School of Medicine highlights the role of the immune system, specifically the STING molecule, in Alzheimer's research.
- Research suggests that DNA damage with aging triggers STING activation, leading to chronic inflammation and neurotoxicity, contributing to Alzheimer's pathology.
- STING's involvement in immune responses in the brain, particularly in microglia, reveals its impact on neurodegeneration and inflammatory processes.
- In lab models, inhibiting STING activity in mice shows significant reductions in amyloid plaques, improved cognitive function, and diminished inflammation.
- STING's role extends to various neurodegenerative diseases, suggesting a potential target for therapies in conditions like Parkinson's and ALS.
- The study connects aging-related DNA damage to immune dysregulation via STING, explaining the vulnerability to Alzheimer's in older individuals.
- Balancing STING's protective and detrimental roles poses a challenge, requiring targeted approaches for potential therapies to minimize unintended consequences.
- Blocking STING appears to modulate immune responses around amyloid deposits, supporting neuronal resilience and influencing inflammatory signaling.
- The study emphasizes the need for personalized approaches in translating preclinical success to human therapies in Alzheimer's treatment.
- Led by Dr. John Lukens, the UVA research signifies the collaborative effort to redefine disease paradigms by merging immunology, neuroscience, and molecular biology.
Read Full Article
6 Likes
Bioengineer
4d
126
Image Credit: Bioengineer
Predicting Tamoxifen Success: Genes and Survival
- A study published in BMC Cancer in 2025 explores how genetic profiles and tamoxifen dosing impact survival outcomes for breast cancer patients, emphasizing the role of the CYP2D6*4 genetic variant and personalized tamoxifen dosage adjustments.
- The research delves into the variability in treatment response due to variances in drug metabolism, particularly influenced by the CYP2D6 enzyme and the CYP2D6*4 allele's impact on tamoxifen efficacy, using real-world evidence from a cohort of 3,218 female breast cancer patients.
- Incremental tamoxifen dose increases over six months show significant decreases in mortality rates, supporting tailored dosing regimens for better outcomes, while patients with the CYP2D6*4 variant exhibit higher mortality risks, especially regarding breast cancer-specific deaths.
- The study challenges prior conflicting findings on CYP2D6 genotyping, highlighting the importance of extended follow-up periods to capture genetic variant impacts accurately on survival, such as the compromised bioactivation of tamoxifen in carriers of the CYP2D6*4 allele.
- The research suggests preemptive genotyping for personalized treatment approaches, considering alternative therapies or dose adjustments for CYP2D6*4 carriers to optimize treatment efficacy and avoid metabolic deficiencies that can lead to poorer clinical outcomes.
- Integrating pharmacogenomics into breast cancer management could significantly enhance therapeutic outcomes by tailoring treatment plans based on genetic profiles, potentially revolutionizing tamoxifen prescribing towards precision oncology for improved survival rates and quality of life for patients globally.
- The study's findings advocate for genetic testing to inform therapeutics, propelling the field towards personalized medicine paradigms and urging stakeholders to reconsider conventional practices, emphasizing a genetics-driven approach to breast cancer care.
- Acknowledging the need for further prospective trials with larger cohorts, the study underscores the transformative potential of pharmacogenomic insights in reshaping clinical decision-making frameworks and advancing precision oncology for enhanced patient outcomes in the future.
- In conclusion, the research defines the CYP2D6*4 variant as a critical prognostic biomarker and establishes a quantitative link between tamoxifen dosage adjustments and survival benefits, signaling a shift towards individualized interventions that promise improved outcomes for breast cancer patients worldwide.
Read Full Article
7 Likes
Discover more
Bioengineer
4d
321
Image Credit: Bioengineer
Egocentric Value Maps Illuminate Near-Body Space
- Neuroscientists have unveiled a framework grounded in reinforcement learning and artificial neural networks that sheds light on the representation and interaction with peripersonal space, revealing egocentric value maps encoding action values associated with interactions in near-body space.
- Body-part-centered neural response fields around limbs, face, or torso were traditionally interpreted as sensory phenomena but are now understood to encode the expected value associated with contact events, integrating sensory inputs for decision making.
- Reinforcement learning paradigms within artificial neural networks simulated agents interacting with objects, showing emergent response fields reflecting computed action values akin to biological neural systems.
- Peripersonal space is seen as an egocentric value map that modularly organizes representations tailored to specific body parts, mirroring brain regions governing sensorimotor coordination.
- This research may lead to applications in robotics and prosthetics, enhancing adaptability and interaction capabilities, while generating testable predictions around dynamic shifts in neural response fields.
- The study's innovation lies in merging computational neuroscience and machine learning, allowing networks to discover optimal representations driven by environmental contingencies and task structure.
- The brain constructs an egocentric map encoding potential rewards and penalties in near-body space, facilitating efficient decision-making and motor planning rooted in the agent’s immediate spatial context.
- These findings challenge classical ideas in cognitive neuroscience by integrating spatial representations with valuation processes, offering a holistic view of how the brain navigates the near-body world.
- Understanding egocentric value maps not only unlocks the neural organization of space but also fosters interdisciplinary exploration, promising insights into embodied cognition and spatial awareness.
- Egocentric value maps redefine peripersonal space as a dynamic and value-driven construct, guiding behavior efficiently and adaptably at the intersection of mind, body, and environment.
Read Full Article
19 Likes
Bioengineer
4d
166
Image Credit: Bioengineer
Proteomic Atlas Reveals Brain Structure-Disorder Links
- Ren, P., Hou, X.H., Li, Z., and colleagues have created an atlas mapping proteomic signatures in the human brain, offering insights into brain function and disorders.
- The study reveals protein expression patterns in different brain regions, linking them to anatomical specialization and susceptibility to neurological disorders.
- By using mass spectrometry and anatomical dissections, the researchers profiled thousands of proteins from various brain areas of healthy donors.
- The atlas highlights protein variances across brain structures and functional networks, shedding light on information processing and energy metabolism.
- Distinct protein signatures associated with conditions like Alzheimer’s, schizophrenia, and epilepsy were identified, hinting at potential biomarkers and therapeutic targets.
- Advanced bioinformatics algorithms identified co-expressed protein clusters related to cellular pathways, emphasizing post-transcriptional regulation in brain function.
- The atlas, known for its methodological rigor, serves as a reliable molecular reference for neuroscience research and clinical studies globally.
- This proteomic focus complements brain mapping projects, providing a deep molecular understanding of brain biology at the protein level.
- The atlas's implications extend to developmental neuroscience, offering insights into brain maturation and neurodevelopmental disorders.
- The study's translational potential includes developing selective drugs, enhancing biomarker discovery, and integrating multi-omics data for comprehensive brain health analysis.
Read Full Article
10 Likes
Bioengineer
4d
142
Image Credit: Bioengineer
S2302 Pragmatica-Lung Emerges as a Model for Faster, Leaner, and More Representative Clinical Trials
- The SWOG S2302 Pragmatica-Lung trial introduces a groundbreaking pragmatic approach to cancer research, aiming to enhance clinical trial efficiency and inclusivity.
- This phase 3 trial focused on evaluating the combination of ramucirumab and pembrolizumab in patients with late-stage non-small cell lung cancer.
- The study's simplified design and broad eligibility criteria facilitated rapid patient enrollment, reflecting the diverse U.S. population affected by advanced lung cancer.
- With 838 participants, including historically underrepresented groups, the trial aimed to validate earlier promising results but ultimately found no significant survival benefit.
- Interim analysis revealed no statistical difference in overall survival between the experimental and standard-of-care arms.
- Subgroup analyses highlighted potential trends in different histological groups, emphasizing the need for continued follow-up to understand nuanced treatment effects.
- Safety monitoring showed no alarming concerns, supporting the ethical conduct of the trial and patient welfare.
- The trial's accelerated timeline, from concept to activation, set a new standard for efficient trial conduct while maintaining scientific rigor.
- Collaboration between regulatory bodies and oncology groups played a pivotal role in the success of the trial, showcasing a model for future research partnerships.
- The pragmatic design and inclusive enrollment approach of Pragmatica-Lung signify a shift towards patient-centered, efficient, and impactful cancer research practices.
Read Full Article
8 Likes
Bioengineer
4d
134
Image Credit: Bioengineer
Attention-Enhanced U-Net Boosts Lymph Node Segmentation
- In the context of medical imaging, lymph node segmentation in uterine MRI scans presents challenges due to unclear boundaries and diverse structures.
- A novel study introduces a deep learning approach combining bimodal MRI and an attention-enhanced U-Net for precise lymph node detection.
- Lymph nodes play a crucial role in gynecological disease diagnosis, and accurate identification is vital for treatment planning.
- The study integrates T2-weighted and diffusion-weighted imaging to enhance automation by providing valuable anatomical information.
- The developed ERU-Net model incorporates efficient channel attention and residual connections for improved lymph node segmentation.
- Data augmentation techniques were used to address dataset limitations, aiding in training and ensuring generalizability.
- Evaluation metrics demonstrated the ERU-Net's high performance with an mIoU of 0.83 and pixel accuracy of 91%.
- Comparative analysis showed the superiority of ERU-Net over conventional U-Net models in uterine lymph node delineation tasks.
- The methodology not only enhances algorithmic accuracy but also streamlines radiological workflows and improves diagnostic efficiency.
- The study's success signifies a significant advancement in MRI-based lymph node segmentation, paving the way for future AI-driven diagnostic tools.
Read Full Article
8 Likes
Bioengineer
4d
81
Image Credit: Bioengineer
Berbamine Boosts FTO to Halt Kidney Cancer
- A recent study has highlighted the potential of berbamine (BBM) in inhibiting the proliferation and invasion of renal cell carcinoma (RCC) cells by boosting the expression of the fat mass and obesity-associated gene (FTO).
- Berbamine, derived from Berberis amurensis, demonstrated significant anti-tumor effects in RCC cell lines, offering a promising avenue for novel therapeutics against metastatic RCC.
- Through in vitro and in vivo experiments, berbamine exhibited dose-dependent inhibition of RCC cell growth, impeded colony formation, disrupted cell cycle progression, and reduced migratory and invasive capabilities.
- The study revealed that berbamine enhances FTO expression at mRNA and protein levels, with FTO acting as a crucial mediator of berbamine's anti-tumor activity in RCC cells.
- Silencing FTO attenuated berbamine's inhibitory effects on RCC cell growth and invasion, emphasizing the significance of the FTO pathway as a potential target for therapeutic intervention.
- In animal models, berbamine significantly suppressed tumor growth without systemic toxicity, positioning it as a promising candidate for clinical development against RCC.
- The research sheds light on berbamine's intricate mechanisms within the RCC microenvironment, highlighting the role of epitranscriptomic regulation in cancer biology and offering a novel approach for cancer treatment.
- The study's findings underscore the therapeutic potential of berbamine in addressing critical aspects of RCC aggressiveness and metastasis, presenting a paradigm shift in combating this challenging malignancy.
- Further research is needed to elucidate the specific downstream targets of FTO influenced by berbamine treatment, paving the way for the development of personalized and effective therapeutic strategies in RCC.
- With its low toxicity profile and natural origin, berbamine holds promise for translational efforts towards clinical trials, offering hope for innovative and biologically inspired therapies for metastatic RCC.
Read Full Article
4 Likes
Bioengineer
4d
138
Image Credit: Bioengineer
Pre-Surgical Immunotherapy Boosts Lung Cancer Survival: Findings from Global Trial Led by Irish Cancer Expert
- A phase 3 clinical trial led by Professor Patrick Forde at Trinity St. James’s Cancer Institute reveals that combining nivolumab with standard chemotherapy before surgery significantly improves long-term survival for patients with non-small cell lung cancer.
- The trial, known as CheckMate 816, challenges prior beliefs by positioning immunotherapy as a potential curative option rather than just palliative care in advanced lung cancer.
- Immunotherapy presents a promising approach to eradicate microscopic residual disease and enhance the chances of durable remission in NSCLC patients.
- The study demonstrates a 10% absolute improvement in 5-year overall survival with the combination therapy compared to chemotherapy alone.
- The safety profile of adding nivolumab to chemotherapy was favorable, without a significant increase in surgical complications or adverse effects.
- Neoadjuvant immunotherapy with nivolumab is being adopted as a new standard of care for resectable NSCLC, signifying a paradigm shift in early-stage lung cancer treatment.
- Ongoing research, like the NeoCOAST-2 trial co-led by Professor Forde, aims to optimize neoadjuvant strategies further and improve patient outcomes with novel approaches.
- The integration of immunotherapy in the neoadjuvant setting aims to reduce disease recurrence risk in lung cancer by enhancing the immune system's response against tumor cells.
- These advancements highlight the crucial role of clinical trials in accelerating innovation and improving treatment options, offering hope for patients with aggressive lung cancer.
- The randomized controlled design of CheckMate 816 ensures the reliability of its findings, influencing global clinical guidelines and shaping the future of NSCLC management.
Read Full Article
8 Likes
Bioengineer
4d
44
Image Credit: Bioengineer
Inflammatory Diseases Linked to Lung Cancer in Never-Smokers
- A recent study published in Nature Communications reveals significant links between chronic inflammatory diseases and the increased risk of lung cancer in individuals who have never smoked, challenging the conventional belief that smoking is the primary cause of lung malignancies.
- While smoking has historically been associated with most lung cancer cases globally, the rise in lung cancer diagnoses among never-smokers has spurred attention towards investigating other potential triggers of cancer development.
- The study focused on various inflammatory conditions, ranging from autoimmune disorders to chronic infections, and their role in promoting neoplastic transformation in lung tissues.
- Chronic inflammation, known for its dual impact on human health, was found to contribute to DNA damage, aberrant cell growth, and evasion of normal growth controls, all precursors to cancer development.
- The research identified a strong correlation between certain inflammatory diseases and an elevated incidence of lung cancer, suggesting that chronic inflammation could independently drive carcinogenesis in never-smokers.
- Genomic analyses of lung tissues from affected individuals indicated genetic alterations commonly seen in lung cancer, alongside increased expression of inflammatory mediators, supporting the connection between inflammation and malignant transformation.
- Inflammation was found to create a tumor-promoting microenvironment in the lungs by altering extracellular matrix components and suppressing immune surveillance mechanisms, facilitating cancer growth and metastasis.
- The study underscores the importance of reevaluating cancer screening protocols to include individuals with chronic inflammatory diseases who may be at risk, as current guidelines primarily focus on smokers and those with exposure histories.
- The findings suggest potential targeted interventions that disrupt inflammatory signaling pathways as a strategy to mitigate both inflammation and tumor initiation, presenting new avenues for therapeutic exploration.
- This research emphasizes the need for personalized risk assessments and interdisciplinary approaches that integrate immunology, oncology, and pulmonology to better understand and address the complexity of lung cancer heterogeneity.
- Longitudinal studies tracking inflammatory biomarkers and genetic changes over time are recommended to enhance our comprehension of inflammation-cancer interplay in the lungs and identify high-risk individuals for preventive strategies.
Read Full Article
2 Likes
Bioengineer
4d
105
Image Credit: Bioengineer
Detecting BPA Analogues in Canadian, South African Milk
- Research reveals the presence of bisphenol A (BPA) analogues and alternatives in human breast milk, raising concerns for infant health and developmental impacts.
- Bisphenols, known for endocrine-disrupting properties, are widely used in plastics and consumer goods, posing a risk to hormonal systems.
- Advanced screening methods detected a range of bisphenol analogues in breast milk, highlighting the need for comprehensive toxicological assessments.
- The study compared milk samples from Canada and South Africa, revealing widespread contamination by bisphenol structural analogues in both regions.
- Endocrine disruptors like bisphenols can impact gene expression, cellular signaling, and developmental processes during critical life stages.
- Technological advancements in suspect screening enable the identification of unknown compounds in human milk, enhancing exposure science.
- Risk assessment of bisphenol substitutes, often marketed as safer alternatives, is crucial in light of their potential comparable toxicological profiles.
- Public health initiatives are needed to educate on sources of bisphenol exposure, advocate for safer consumer choices, and promote chemical transparency.
- Longitudinal studies correlating bisphenol levels in breast milk with child health outcomes are essential to understand the impact of exposure.
- Collaboration among disciplines is key to elucidating risks and developing mitigation strategies for bisphenol contamination in human biological systems.
Read Full Article
6 Likes
Bioengineer
5d
179
Image Credit: Bioengineer
Self-Powered Artificial Synapse Replicates Human Color Vision
- Researchers at the Tokyo University of Science have developed a self-powered artificial synapse that replicates human color vision, enhancing machine vision systems.
- The innovation emulates the human visual system, enabling efficient visual processing with minimal energy consumption.
- This advancement could improve visual recognition technologies in smartphones, drones, and autonomous vehicles.
- Current machine vision systems struggle with processing large amounts of data, leading to high power and storage requirements.
- The artificial synapse developed by Associate Professor Takashi Ikuno utilizes dye-sensitized solar cells to generate energy from solar illumination and enhance color discrimination.
- The device achieves precision in color recognition with a 10 nanometer accuracy across the visible spectrum, approaching human vision capabilities.
- Experiments showed that the artificial synapse exhibited bipolar voltage responses to different light wavelengths, enabling complex computational functions in machine vision applications.
- The technology promises advancements in areas such as transportation, healthcare, and consumer electronics, with potential applications in autonomous vehicles, healthcare wearables, and smartphones.
- Dr. Ikuno highlights the potential for low-power machine vision systems with color discrimination and real-time logical operations, surpassing traditional systems in certain aspects.
- The research signifies a significant milestone in developing more efficient and sustainable machine vision technologies, paving the way for innovative sensory technology integration.
Read Full Article
10 Likes
Bioengineer
5d
216
Image Credit: Bioengineer
Breast Cancer Rates in Indonesia: Gender Insights
- A recent study on breast cancer in Indonesia using WHO Health Equity Assessment Toolkit data reveals persistent disparities in breast cancer incidence between genders, highlighting the need for public health interventions.
- The research analyzes age-standardized breast cancer rates from 2000 to 2019, showing a decline in overall incidence but significant disparities between women and men.
- In 2019, women in Indonesia had a much higher breast cancer incidence rate compared to men, emphasizing the substantial gender gap in breast cancer risk.
- Quantifying these disparities through various indicators underlines the impact on women, with nearly all breast cancer cases being attributed to the female sex.
- The study highlights the complex interplay of genetic, hormonal, lifestyle, and environmental factors influencing breast cancer disparities in Indonesia.
- Challenges in healthcare infrastructure and unequal access to screening and treatment services contribute to higher breast cancer mortality, especially in rural areas.
- The study emphasizes the importance of expanding organized breast cancer screening programs and improving healthcare infrastructure and diagnostic capabilities in Indonesia.
- Research on female-specific risk factors, including hormonal, reproductive, and lifestyle aspects, is crucial for understanding and addressing breast cancer disparities.
- Addressing social determinants of health such as education and income disparities is essential for reducing breast cancer inequities among Indonesian women.
- A collaborative approach involving government agencies, healthcare providers, and community organizations is vital for implementing effective interventions that cater to women across diverse Indonesian regions.
Read Full Article
12 Likes
Bioengineer
5d
57
Image Credit: Bioengineer
Dual SORT LNPs Enable Multi-Organ Base Editing
- Researchers have developed Dual SORT LNPs, a lipid nanoparticle system enabling precise base editing in both the liver and lungs for genetic diseases like Alpha-1 antitrypsin deficiency (AATD). AATD affects liver and lung function due to mutated SERPINA1 gene causing misfolded A1AT proteins and insufficient enzyme inhibition, respectively.
- The innovative base editing strategy addresses the complex pathology of AATD in multiple organs, where conventional therapies have limitations in delivering genetic medicines effectively to diverse tissues.
- Dual SORT LNPs allow efficient co-delivery of base editors to liver and lung cells, achieving significant correction rates in liver and lung AT2 cells essential for AATD pathology.
- The base editing persistence over a 32-week period in liver cells resulted in a substantial reduction of Z-allele A1AT protein levels, normalizing hepatic function and mitigating liver disease progression.
- In the lungs, the correction led to a notable reduction in neutrophil elastase activity, indicating mitigation of pulmonary damage pathways and potential alleviation of emphysema.
- The precise organ targeting of Dual SORT LNPs, with tailored lipid formulations, enhances selective delivery to specific cellular microenvironments, minimizing off-target effects and systemic toxicity.
- This breakthrough paves the way for future applications of dual-organ gene editing therapies, with promising safety profiles and potential for broadening the approach to treat other multi-organ genetic diseases.
- The innovation signifies a paradigm shift in genetic medicine by integrating precision editing with targeted delivery to address systemic diseases effectively, transforming untreatable conditions into manageable or curable illnesses.
- Further optimization of Dual SORT LNPs could involve customization for additional tissues, scale-up of manufacturing, and integration of next-generation base editors to enhance editing precision and scope.
- This groundbreaking technology offers a tangible pathway towards durable cures for complex genetic diseases, reshaping therapeutic genome editing and providing hope for millions affected by multisystemic genetic conditions.
- Author: Researchers Kim, Song, and Chen. Article Title: Dual SORT LNPs for multi-organ base editing. Published in Nature Biotechnology (2025).
Read Full Article
3 Likes
For uninterrupted reading, download the app